At a glance
- Originator Pfizer
- Class Piperidines; Small molecules
- Mechanism of Action Matrix metalloproteinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 23 Feb 2009 Discontinued - Preclinical for Cancer in USA (unspecified route)
- 16 Apr 2003 Pharmacia Corporation has been acquired by, and merged into, Pfizer
- 21 Sep 2001 Preclinical development for Cancer in USA (Unknown route)